Surgical Site Infection in Caesarean Section Using Alexis O Compared to Metal Retractors
NCT ID: NCT02685696
Last Updated: 2016-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2013-10-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate if the use of the newly designed Alexis O Retractor leads to improved intra-operative and post-operative surgical outcomes in the setting of planned elective Caesarean Sections.
Study Design:
This ethically approved study is designed as a prospective, randomized controlled trial in planned, first time Caesarean Sections with 200 patients randomized to either the Alexis-O Retractor group or the conventional group. Patients with wound healing problems, connective tissue disorders, insulin dependent diabetes, bleeding disorders, previous major abdominal surgery and chorioamnionitis are excluded. Outcomes include surgical site infection, intraoperative parameters such as tissue damage, postoperative analgesia requirements and patient satisfaction scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alexis O-Ring Wound Retractor for the Prevention of Post-cesarean Surgical Site Infections
NCT03365219
Wound Infection Alexis Wound Retractor
NCT00323453
Plastic Wound Retractors and Bacterial Translocation in Abdominal Surgery
NCT01007487
Prospective, Randomized, Parallel-arm Clinical Trial of CleanCision or Alexis O in Elective Colorectal Surgery
NCT03816995
Abdominal Closure Bundle to Reduce Surgical Site Infection in Patients Undergoing C-sections. Cesarean Section Lead to Reduction in Surgical Site Infection? - A Randomized Controlled Trial
NCT03500055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Does the use of the newly designed Alexis O Retractor lead to improved Surgical Site Infection rates intra-operative and post-operative surgical outcomes in the setting of planned elective first time Caesarean Sections in patients compared to the traditional self-retaining metal retractor?
Secondary Hypotheses:
Does the Alexis O Retractor lead to improved intra-operative and post-operative surgical outcomes in the setting of planned elective Caesarean Sections?
Study Design:
The Study is designed as a prospective, randomized controlled trial with 100 patients randomized to the Alexis O Retractor group and 100 patients to the conventional group.
All patients will be recruited following a thorough discussion about the purpose and methodology of the study and full documented consent will be obtained prior to randomization.
Patients with wound healing problems, connective tissue disorders, diabetes, bleeding disorders, previous abdominal surgery apart from laparoscopy and chorioamnionitis will be excluded.
All surgical operators are thoroughly trained in the use and application of the Alexis O Retractor prior to the start of the study and supported by regular teaching demonstrations. The Obstetric Theatre Team is informed and trained in use and application of the Alexis O Retractor within the Study Design.
Ethical Approval:
Ethical Approval has already been obtained from the Ethics committee at the Charité University Hospital Committee and in keeping with ethical standards.
Statistics:
* Data analysis and statistical comparisons will be performed by the appropriate robust statistical methodology.
* Comparisons to be investigated
* Subjective Assessment of the Ease of Application of Retractor Instrument
* Incision to Delivery Time
* Incision to Skin Suture Time
* Subjective Assessment of Visualized Operative Field
* Subjective Assessment of Freedom of Surgical Movement
* Interference from Descending Bowel or Adnexal Tissue
* Bowel and Bladder Trauma
* Need for Bowel Packing
* Need for Paracolic Cleaning of Blood and Amniotic Fluid
* Need for Uterus Exteriorization Intraoperatively
* Fascial Trauma
* Muscle Trauma
* Muscle Suturing
* Coagulation of the Subcutaneous Tissue
* Subcutaneous Tissue Thickness
* Skin Lacerations
* Trauma to the Baby
* Estimated Blood Loss
* Ease of Retractor Removal
* Analgesia Requirements Post Operative
* Wound Healing Problems on Discharge and at 6 Weeks (Telephone Interview)
* Wound Infections (As defined by Centers for Disease Control)
* Time to Hospital Discharge
* 6-Week Scar Pain Scores (Telephone Interview)
* Patient Satisfaction with Wound Healing (Telephone Interview)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alexis O Retractor
Group 1 received the Alexis-O-Retractor at thet time of first Caesarean Section
Alexis O Retractor
A newly developed abdominal wall retractor for Caesarean Section is the Alexis O Ring which is formed of 2 rings and a interconnecting plastic polyurethane sheath where the flexible inner ring is placed into the abdomen and where the rigid outer ring is rolled to create tension on the plastic sheath providing 360° abdominal wound retraction with simultaneously a tamponade effect whilst covering the abdominal wound during the Caesarean Section and delivery of the baby.
Metal Retractor
Group 2 received the traditional self retaining metal Retractor at thet time of first Caesarean Section
Metal Retractor
The traditional self-retaining metal Collins Caesarean Wound Retractor.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alexis O Retractor
A newly developed abdominal wall retractor for Caesarean Section is the Alexis O Ring which is formed of 2 rings and a interconnecting plastic polyurethane sheath where the flexible inner ring is placed into the abdomen and where the rigid outer ring is rolled to create tension on the plastic sheath providing 360° abdominal wound retraction with simultaneously a tamponade effect whilst covering the abdominal wound during the Caesarean Section and delivery of the baby.
Metal Retractor
The traditional self-retaining metal Collins Caesarean Wound Retractor.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective Caesarean Section
* First Caesarean Section
Exclusion Criteria
* Chronic auto immune diseases
* Lupus
* Immune deficiency diseases
* HIV
* known bleeding disorders
* full anti-coagulation therapy
* wound healing problems
* previous Caesarean Section
* major abdominal surgery
* laparotomy
* active phase of labor
* suspected chorioamnionitis
* confirmed chorioamnionitis
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Larry Hinkson
Consultant in Obstetrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Larry Hinkson, MBBS,MRCOG
Role: PRINCIPAL_INVESTIGATOR
Charité University Hospital
References
Explore related publications, articles, or registry entries linked to this study.
Klingel ML, Patel SV. A meta-analysis of the effect of inspired oxygen concentration on the incidence of surgical site infection following cesarean section. Int J Obstet Anesth. 2013 Apr;22(2):104-12. doi: 10.1016/j.ijoa.2013.01.001. Epub 2013 Mar 13.
Horiuchi T, Tanishima H, Tamagawa K, Sakaguchi S, Shono Y, Tsubakihara H, Tabuse K, Kinoshita Y. A wound protector shields incision sites from bacterial invasion. Surg Infect (Larchmt). 2010 Dec;11(6):501-3. doi: 10.1089/sur.2009.072. Epub 2010 Sep 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AlexisO1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.